Valerie Chew
Assoc Prof. Valerie Chew, PhD, Translational Immunology Institute (TII), Singapore, is a Principal Investigator at TII and Associate Professor at Duke-NUS Medical School, Singapore. A key opinion leader in liver cancer immunology, Dr. Chew’s research focuses on elucidating the complex and diverse immune contexture within the tumor microenvironment of patients with hepatocellular carcinoma (HCC). She leverages advanced single-cell and spatial technologies including CyTOF, single-cell RNA sequencing, and spatial transcriptomics, to perform multi-dimensional immune profiling and identify clinically relevant biomarkers and therapeutic targets. Dr. Chew serves on the Editorial board of leading journals including the Journal of Hepatology (IF:40.1) , Clinical and Molecular Hepatology (IF:21.7) and Liver Cancer (IF:9.1), and Nature Reviews Gastroenterology & Hepatology (IF:51). She is also the Treasurer and a Governing Board Member of the International Liver Cancer Association (ILCA) as well as vice president of Singaporean Society for Immunology (SgSI), where she contributes to global efforts in liver cancer and immunology research, education, and policy development.
Abstracts this author is presenting: